Colombia To Link New Medicine Prices To Therapeutic Value
Executive Summary
Companies will face new therapeutic evaluations in Colombia to help determine the price of their new drugs.
You may also be interested in...
EFPIA Works To Get Industry View Included In Horizon Scanning Initiatives
The European Federation of Pharmaceutical Industries and Associations is preparing its principles on horizon scanning.
Colombia’s New Pricing Decree Could Impact Drug Registration, Warns Industry Group
The pharmaceutical industry in Colombia is concerned that a new pricing decree could impact the regulatory process for new drugs.
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.